The current management of malignant bone tumours: where do we go from here?
- 1 April 1988
- journal article
- research article
- Published by Wiley in The Medical Journal of Australia
- Vol. 148 (8) , 373-377
- https://doi.org/10.5694/j.1326-5377.1988.tb115957.x
Abstract
Click on the article title to read more.This publication has 12 references indexed in Scilit:
- Multidisciplinary treatment of primary Ewing's sarcoma of bone.A 6-year experience of a European cooperative trialCancer, 1988
- Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.Journal of Clinical Oncology, 1987
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bonesInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.Journal of Clinical Oncology, 1984
- A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma.Journal of Clinical Oncology, 1984
- Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapyCancer, 1982
- CISPLATIN IN METASTATIC OSTEOGENIC SARCOMAPublished by Elsevier ,1980
- Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgeryCancer, 1979
- Disease-free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapyCancer, 1974